Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5291954 Target Snapshot

Alpha-glucosidase · PROTEIN FAMILY · Saccharomyces cerevisiae S288c

534Compounds
192Assays
4Approved Drugs
589.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P53341. Use UniProt P53341 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P53341 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Alpha-glucosidase as ChEMBL target CHEMBL5291954, mapped to UniProt P53341. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Alpha-glucosidase
PROTEIN FAMILY · Saccharomyces cerevisiae S288c
As of 2026-09-14
ChEMBL target ID
CHEMBL5291954
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P53341
Alpha-glucosidase MAL12
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Alpha-glucosidase is the right protein anchor across sources, using UniProt P53341 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAlpha-glucosidase MAL12
UniProt AccessionP53341
Component TypeProtein
Sequence Length584 aa

Alpha-glucosidase MAL12

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Alpha-glucosidase, mapped to UniProt P53341. ChEMBL maps the protein component as Alpha-glucosidase MAL12. Sequence length is 584 aa.

Mapped IDP53341
Review nameAlpha-glucosidase
OrganismSaccharomyces cerevisiae S288c
Clinical Profile

Clinical Phase Distribution

4
Approved
2
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50539.0
KI50.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5402358 7.55 IC50 28.47 Preclinical
CHEMBL450152 7.4 IC50 40.0 Preclinical
CHEMBL5272219 6.96 IC50 110.0 Preclinical
CHEMBL5561939 6.82 Ki 150.0 Preclinical
CHEMBL5561939 6.75 IC50 180.0 Preclinical
CHEMBL4435163 6.62 IC50 240.0 Preclinical
CHEMBL5647031 6.52 IC50 300.0 Preclinical
CHEMBL138007 6.38 Ki 420.0 Preclinical
CHEMBL1467423 6.38 Ki 420.0 Preclinical
CHEMBL5646841 6.14 IC50 730.0 Preclinical
Distribution

pChEMBL Value Distribution

70
5.0
63
5.5
12
6.0
5
6.5
1
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

192
Total Assays
411
Tested Compounds
1
Assay Types
Binding — 192 assays, 411 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 192 411 4.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine